ALEC: Alector, Inc. Stock

by  •  • Comments Off on ALEC: Alector, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 111.49
Enterprise Value ($M) 82.98
Book Value ($M) 94.61
Book Value / Share 0.95
Price / Book 1.18
NCAV ($M) 52.96
NCAV / Share 0.53
Price / NCAV 2.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.91
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.69

Liquidity (mrq)
Quick Ratio 3.34
Current Ratio 3.34

Balance Sheet (mrq) ($M)
Current Assets 366.65
Assets 408.30
Liabilities 313.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 100.56
Operating Income -142.79
Net Income -119.05
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -229.91
Cash from Investing 107.13
Cash from Financing 81.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-17 13G/A BlackRock, Inc. 6.20 -24.19
12-06 13G Ra Capital Management, L.p. 9.90
11-12 13G/A Polaris Venture Partners VI, L.P. 10.20 -9.09
11-07 13G/A Morgan Stanley 4.50 -5.94

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 299,354 856,548 34.95
2025-05-12 162,793 1,092,368 14.90
2025-05-09 205,449 1,334,641 15.39
2025-05-08 169,529 696,491 24.34

(click for more detail)

Similar Companies
ADPT – Adaptive Biotechnologies Corporation AGIO – Agios Pharmaceuticals, Inc.
AKRO – Akero Therapeutics, Inc. ALKS – Alkermes plc
ALLK – Allakos Inc.


Financial data and stock pages provided by
Fintel.io